Why Read IN VIVO?
IN VIVO is the only strategically-focused business resource covering the global medical industry. IN VIVO delivers revealing, in-depth coverage of your competitors' strategies; incisive projections of future industry trends and their implications for your business; expert analysis of key industry developments; exclusive interviews with top industry executives and analysts; and in-depth examination of dealmaking, marketing R&D, regulatory, and finance strategies.
Who Reads IN VIVO?
IN VIVO is read by top executives and decision makers in the global health care marketplace within the biopharma, medtech, and diagnostics industries. It is the top executives resource for informed, effective, profitable decision-making, because it delivers the insight they need to construct winning strategies, combat competitors' plans, and anticipate future industry and market developments.
Subscription Terms
Subscription Options
Buy Now
Includes:
Email newsletter with latest headlines, breaking news alerts, and access to IN VIVO — the premier strategic business resource for the biopharma, medtech, and diagnostics industries.
Multiple users/site features: Contact Deanna Flanick at +1-908-547-2141 or D.Flanick@Elsevier.com.